BKV vs PTEN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The company exhibits a weak Piotroski F-Score of 4/9, indicating borderline financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite strong recent earnings and revenue growth, elevated valuation metrics, declining insider sentiment, and weak technicals suggest caution. The stock trades significantly above both the Graham Number ($14.69) and intrinsic value ($14.16), implying a premium priced on future growth. While analyst consensus is strong_buy, insider selling and deteriorating short-term EPS momentum present countervailing risks.
PTEN exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 2/9, indicating a deteriorating financial position. While the stock has seen a strong 1-year price increase, this is disconnected from operational reality: the company reports negative profit margins and an unsustainable dividend payout ratio of 213.33%. Bearish insider sentiment and negative revenue growth further undermine the bullish analyst consensus. The combination of operational inefficiency and capital mismanagement suggests a high risk of a price correction.
Compare Another Pair
Related Comparisons
BKV vs PTEN: Head-to-Head Comparison
This page compares BKV Corporation (BKV) and Patterson-UTI Energy, Inc. (PTEN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.